More than a third of gynecologic cancer patients used cannabis, mostly without a prescription

Among 46 gynecologic cancer patients surveyed at a Canadian cancer center, 37% were current cannabis users, primarily for pain, anxiety, and insomnia, and most obtained it without a prescription.

Black, Kristin A et al.·Gynecologic oncology reports·2023·Preliminary EvidenceCross-Sectional
RTHC-04419Cross SectionalPreliminary Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Preliminary Evidence
Sample
N=46

What This Study Found

Of 46 surveyed patients, 17 (37%) were current cannabis users. The most common reasons were pain (9/17), anxiety (9/17), and insomnia (9/17). Most users lacked a prescription (11/17 obtained cannabis from recreational dispensaries) and half had not discussed their use with their doctor, though over 50% of all patients said they would welcome physician-initiated conversations about cannabis.

Key Numbers

46 participants; 17 (37%) current users; pain, anxiety, insomnia each cited by 9/17 users; 11/17 obtained from recreational dispensary; 9/17 had not discussed with doctor; 26/46 would discuss if physician raised it; cannabis retailers (20/46) and friends/family (20/46) were top info sources

How They Did This

Single-institution cross-sectional survey conducted at a cancer center in Calgary, Alberta. Patients with current or prior gynecologic cancer diagnosis were surveyed about cannabis use patterns, reasons for use, and information sources.

Why This Research Matters

Cannabis use among cancer patients is common but often undisclosed to oncologists. The finding that most patients would welcome physician-initiated conversations suggests a gap between patient interest and clinical practice.

The Bigger Picture

When patients get cannabis information primarily from retailers and friends rather than clinicians, they may make decisions without considering drug interactions or evidence-based alternatives.

What This Study Doesn't Tell Us

Small sample (n=46) from a single Canadian cancer center. Self-selected participation may overrepresent cannabis users. Cross-sectional design cannot track use patterns over treatment course.

Questions This Raises

  • ?Do cannabis-using cancer patients experience different treatment outcomes?
  • ?What training would help oncologists discuss cannabis more effectively with patients?

Trust & Context

Key Stat:
37% of gynecologic cancer patients were current cannabis users
Evidence Grade:
Small single-site survey with self-selected participants; provides descriptive data but limited generalizability.
Study Age:
Published 2023
Original Title:
Cannabis use in gynecologic cancer patients in a Canadian cancer center.
Published In:
Gynecologic oncology reports, 47, 101210 (2023)
Database ID:
RTHC-04419

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

How common is cannabis use among gynecologic cancer patients?

In this Canadian survey, 37% of gynecologic cancer patients reported current cannabis use, primarily for pain, anxiety, and insomnia.

Do cancer patients discuss cannabis with their doctors?

About half of cannabis-using patients had not discussed it with their doctor, but over 50% of all patients said they would be interested in discussing cannabis if their physician raised the topic.

Read More on RethinkTHC

Cite This Study

RTHC-04419·https://rethinkthc.com/research/RTHC-04419

APA

Black, Kristin A; Bowden, Sylvie; Thompson, Mary; Ghatage, Prafull. (2023). Cannabis use in gynecologic cancer patients in a Canadian cancer center.. Gynecologic oncology reports, 47, 101210. https://doi.org/10.1016/j.gore.2023.101210

MLA

Black, Kristin A, et al. "Cannabis use in gynecologic cancer patients in a Canadian cancer center.." Gynecologic oncology reports, 2023. https://doi.org/10.1016/j.gore.2023.101210

RethinkTHC

RethinkTHC Research Database. "Cannabis use in gynecologic cancer patients in a Canadian ca..." RTHC-04419. Retrieved from https://rethinkthc.com/research/black-2023-cannabis-use-in-gynecologic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.